Historical Valuation
Twist Bioscience Corp (TWST) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.60 is considered Undervalued compared with the five-year average of -17.23. The fair price of Twist Bioscience Corp (TWST) is between 46.78 to 61.70 according to relative valuation methord. Compared to the current price of 35.66 USD , Twist Bioscience Corp is Undervalued By 23.77%.
Relative Value
Fair Zone
46.78-61.70
Current Price：35.66
23.77%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Twist Bioscience Corp (TWST) has a current Price-to-Book (P/B) ratio of 4.15. Compared to its 3-year average P/B ratio of 3.70 , the current P/B ratio is approximately 12.34% higher. Relative to its 5-year average P/B ratio of 4.72, the current P/B ratio is about -11.99% higher. Twist Bioscience Corp (TWST) has a Forward Free Cash Flow (FCF) yield of approximately -3.82%. Compared to its 3-year average FCF yield of -8.40%, the current FCF yield is approximately -54.53% lower. Relative to its 5-year average FCF yield of -7.63% , the current FCF yield is about -49.98% lower.
P/B
Median3y
3.70
Median5y
4.72
FCF Yield
Median3y
-8.40
Median5y
-7.63
Competitors Valuation Multiple
AI Analysis for TWST
The average P/S ratio for TWST competitors is 12.52, providing a benchmark for relative valuation. Twist Bioscience Corp Corp (TWST.O) exhibits a P/S ratio of 4.60, which is -63.22% above the industry average. Given its robust revenue growth of 16.88%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for TWST
1Y
3Y
5Y
Market capitalization of TWST increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TWST in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is TWST currently overvalued or undervalued?
Twist Bioscience Corp (TWST) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.60 is considered Undervalued compared with the five-year average of -17.23. The fair price of Twist Bioscience Corp (TWST) is between 46.78 to 61.70 according to relative valuation methord. Compared to the current price of 35.66 USD , Twist Bioscience Corp is Undervalued By 23.77% .
What is Twist Bioscience Corp (TWST) fair value?
TWST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Twist Bioscience Corp (TWST) is between 46.78 to 61.70 according to relative valuation methord.
How does TWST's valuation metrics compare to the industry average?
The average P/S ratio for TWST's competitors is 12.52, providing a benchmark for relative valuation. Twist Bioscience Corp Corp (TWST) exhibits a P/S ratio of 4.60, which is -63.22% above the industry average. Given its robust revenue growth of 16.88%, this premium appears unsustainable.
What is the current P/B ratio for Twist Bioscience Corp (TWST) as of Jan 10 2026?
As of Jan 10 2026, Twist Bioscience Corp (TWST) has a P/B ratio of 4.15. This indicates that the market values TWST at 4.15 times its book value.
What is the current FCF Yield for Twist Bioscience Corp (TWST) as of Jan 10 2026?
As of Jan 10 2026, Twist Bioscience Corp (TWST) has a FCF Yield of -3.82%. This means that for every dollar of Twist Bioscience Corp’s market capitalization, the company generates -3.82 cents in free cash flow.
What is the current Forward P/E ratio for Twist Bioscience Corp (TWST) as of Jan 10 2026?
As of Jan 10 2026, Twist Bioscience Corp (TWST) has a Forward P/E ratio of -20.96. This means the market is willing to pay $-20.96 for every dollar of Twist Bioscience Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Twist Bioscience Corp (TWST) as of Jan 10 2026?
As of Jan 10 2026, Twist Bioscience Corp (TWST) has a Forward P/S ratio of 4.60. This means the market is valuing TWST at $4.60 for every dollar of expected revenue over the next 12 months.